Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

Market Cap	6.90B
Revenue (ttm)	5.89B
Net Income (ttm)	83.80M
Shares Out	1.90B
EPS (ttm)	0.04
PE Ratio	89.17
Forward PE	n/a
Dividend	0.06 (1.65%)
Ex-Dividend Date	May 21, 2025

Volume	14,649,900
Average Volume	16,374,818
Open	3.570
Previous Close	3.640
Day's Range	3.570 - 3.650
52-Week Range	2.860 - 4.850
Beta	0.51
RSI	56.92
Earnings Date	Aug 29, 2025

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally. The company offers cardiovascular and cerebrovascular, digestive system, endocrine system, etc. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 5,059
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002390

Financial Performance

In 2024, SHE:002390's revenue was 6.03 billion, a decrease of -6.63% compared to the previous year's 6.46 billion. Earnings were 101.38 million, a decrease of -64.70%.